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Abstract
Background: Sensitization to hazelnut allergens vary depending on the geographic origin and age of the patients.
The objective of this study was to further investigate the allergenic activity of hazelnut allergens using sera from
patients recruited in various European regions and presenting different sensitization patterns to hazelnut proteins.
Methods: Natural Cor a 11 and Cor a 9 were purified from hazelnut whereas Cor a 1 and Cor a 8 were produced
as recombinant proteins (rCor a 1.04 and rCor a 8). Sera from hazelnut allergic patients were collected in France
(n = 5), Switzerland (n = 2), Greece (n = 11) and Spain (n = 3), within the Europrevall project. Total and allergen-specific
IgE were quantified by enzyme allergosorbent test and IgE immunoblot were performed using pooled sera from
birch-pollen endemic region or from Greece. Histamine Release (HR) assays were performed with stripped basophils
passively sensitized with individual sera and challenged by a hazelnut extract or the different hazelnut allergens.
Results: As previously described, hazelnut allergic patients from Mediterranean countries are mainly sensitized to the
nsLTP Cor a 8 whereas patients from France and Switzerland are sensitized to pollen-related allergens. Interestingly, an
intermediate profile was evidenced in patients from Madrid. Hazelnut 7S globulin (Cor a 11) and 11S globulin (Cor a 9)
were found to be minor allergens, recognized only by patients from Mediterranean countries. The biologic activity of
the 4 tested allergens, analysed by HR assay, further confirmed the sensitization patterns, but also demonstrated the
very high elicitation potency of Cor a 8.
Conclusions: This work, extending previously published researches, represents a step towards the better
understanding of the complexity of hazelnut allergy and provides new data on the biological activity of hazelnut
allergens and extracts.
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Background
Recently, Europrevall data demonstrated that hazelnut
(Corylus avellana) is one of the most common trigger of
IgE mediated food allergies. In fact, a very high preva-
lence rate of sensitization to hazelnut was evidenced in
adults, reaching a mean value of 9.3 % of the general
population aged 20–57 years in eight European centers
[1]. Prevalence was however variable between centers,
ranging from 1.27 % in Reykjavik to 17.79 % in Zurich.
Hazelnut allergy was also the most reported food allergy
in Europrevall clinic survey (32 %), with frequencies ran-
ging from 68.4 % in Vilnius to 5.7 % in Madrid [2].
Hazelnut allergy involved different kind of allergens, that
is type 1 (“complete”) or type 2 (“incomplete”) allergens,
leading to different symptoms. Allergic reaction induced
by type 2 hazelnut allergens occurred in patients primary
sensitized to pollen allergens, mainly from birch. The
later consumption of hazelnut, containing proteins hom-
ologous to the sensitizing aeroallergen, will lead to
symptoms localized to the oral cavity (Oral Allergy Syn-
drome–OAS; [3]). Type 1 allergens are able both to
sensitize and to elicit an allergic reaction and induce
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more severe reactions such as urticaria, angiodaema or
anaphylaxis. Those symptoms are evidenced in “true
food allergic” patients [4, 5].
IgE sensitization to hazelnut then combined both IgE
recognition of allergens cross reacting with pollen aller-
gens of the PR-10 family, i.e., Bet v 1-related (Cor a 1),
and profilin (Cor a 2), and true food allergens such as
the non-specific Lipid Transfer Protein (LTP) Cor a 8
and the seed storage proteins Cor a 9 (11S globulin),
Cor a 11 (7S globulin) and Cor a 14 (2S albumin). In
fact, different proteins have been involved as allergens in
hazelnut, the prevalence of specific ones being related to
geographical origin and age [4, 6, 7]. Predominance of
sensitization to the Bet v 1 related protein Cor a 1.04 is
mainly observed in birch-endemic region, i.e., Northern
and Central Europe, whereas Cor a 8 is more implicated
in non-birch endemic Mediterranean regions such as
Spain and Greece [2, 4, 5, 8, 9]. Sensitization to Cor a 8
purified from hazelnut was also evidenced in children
from birch-endemic area, i.e., the Netherlands, in which
it was associated to more severe allergic reaction upon
challenge [9]. However, this was not confirmed in a later
study using recombinant Cor a 8 (rCor a 8), suggesting a
contamination of the natural Cor a 8 by other seed stor-
age proteins [6, 8, 10].
Hazelnut allergy in birch-endemic region was also dem-
onstrated to exhibit age-related sensitization profiles with
different clinical outcomes. Young children (<2 years)
demonstrated more severe reaction with systemic reac-
tion, without associated birch-pollen allergy. Sixty five per-
cent of these children were sensitized to Cor a 9.
Sensitization to Cor a 9 decreased with age, and OAS pre-
dominated in adults, 90 % of which were sensitized to Cor
a 1.04 [6]. In the same birch-endemic region, out of 34
children of less than 1-year-old demonstrating atopic
dermatitis, 20 demonstrated IgE reactivity to hazelnut and
15 to peanut. Of the hazelnut sensitized children, 75 %
demonstrated anti-Cor a 9 IgE, whereas no sensitization
to Cor a 1 nor Cor a 8 was evidenced [11]. Sensitization to
Cor a 9 and Cor a 11 was further evidenced mainly in chil-
dren with systemic reaction in the same birch-endemic
area [7]. Sensitization to Cor a 9 and/or Cor a 14 was later
demonstrated to identify almost 90 % of children with
generalized reactions [12]. In a Dutch hazelnut-sensitized
population, sensitization and levels of specific IgE to Cor a
9 and to the 2S albumin Cor a 14 were also significantly
more common in both children and adults patients dem-
onstrating objective symptoms compared to patients with
no or subjective symptoms [10]. Sensitization to the basic
subunit of an isoform of Cor a 9 was also recently de-
scribed in an Italian pediatric population demonstrating
severe symptoms (urticarial, angioedema and/or anaphyl-
axis), and may be involved in cross-reactivity between nuts
and legumes. In this population, Cor a 8 and Cor a 9 were
also recognized by 47 and 80 % of the patients, respect-
ively [13].
The objective of the present study was then to further
assess the allergenic activity of the hazelnut allergens
using Histamine Release (HR) assays and sera from pa-
tients recruited in various European regions, i.e., France,
Switzerland, Spain and Greece. Sensitization patterns to
hazelnut proteins were first assessed by specific IgE
measurement and IgE immunoblots to confirm regional
variations.
Methods
Allergic patients
Sera of patients with a self-reported hazelnut allergy
have been collected within the Europrevall project in
Switzerland (Zurich), East of France (Strasbourg),
Greece (Athens) and Spain (Madrid) (Table 1; n = 21). A
written informed consent was obtained before the serum
collection and the performed experiments were ap-
proved by the corresponding local ethical committees.
Natural allergen purification and recombinant allergens
Natural Cor a 11 and Cor a 9 were purified from hazel-
nut as described in [14]. Cor a 1.04 and Cor a 8 were
produced as recombinant proteins [15] and kindly pro-
vided by the EuroPrevall allergen library. Hazelnut pro-
teins correspond to RefLab Hazelnut extract (Histamine
release) or were extracted from hazelnut flour (IgE-immu-
noblot, The Nutt Ranch, Marlborough, New Zealand;
Kindly provided by Dr Justin Marsh, University of Man-
chester) using 0.3 % Sodium Borate, 10 mM EDTA, 0.9 %
n-octyl-β-D-Glucoside pH 9.0 buffer. Protein extraction
efficiency was about 80 % considering theoretical protein
content of hazelnut flour.
Determination of total and specific IgE concentrations
Total IgE and IgE specific for Cor a 11, Cor a 9, rCor a
1.04 and rCor a 8 were quantified by EAST (enzyme
allergo-sorbent test) as previously described [16–18].
Briefly, microtitre plates (96 well microtiter MaxiSorp
Nunc, Roskilde, Denmark) were coated by passive ad-
sorption of purified hazelnut proteins (specific IgE) or
anti-human IgE antibody (total IgE, clone LE-27) (5 μg/
ml in 50 mM phosphate buffer, pH 7.4). After saturation
with EIA buffer (0.1 M phosphate buffer, 0.1 % bovine
serum albumin, 0.15 M NaCl, 0.01 % sodium azide,
pH 7.4), 50 μl per well of serial dilutions of individual
serum (1/4 to 1/2500, in EIA buffer) were dispensed.
After a 24-h incubation at 4 °C and a wash step, a sec-
ond anti-human IgE antibody (clone BS17) labelled with
acetylcholinesterase (AChE) was used as tracer. After ex-
tensive washings, Ellman’s reagent was used as enzyme
substrate and the absorbance was measured at 414 nm.
Limit of detection, corresponding to the mean background
Blanc et al. Clinical and Translational Allergy  (2015) 5:26 Page 2 of 9
value plus three standard deviation, was 0.1 IU/ml. Total
IgE concentration was determined as described in [18]
using anti-IgE coated plate and human IgE samples
(World Health Organization) at concentrations ranging
from 10 to 0.08 IU/ml as standard.
IgE-immunoblot
SDS-PAGE and IgE immunoblot analyses were per-
formed using apparatus and reagents from Invitrogen
(Life Technologies, Carlsbad, CA, USA) following pro-
vider’s recommendation. Samples and molecular-weight
markers (See Blue prestained marker) were loaded on a
NuPage Novex 4-12 % Bis-Tris Gel (1.0 mm). Electro-
phoresis was performed using XCell SureLock Mini-Cell
in MES Buffer with a constant voltage of 200 V during
40 min. After electrophoresis, gels were stained with
SimplyBlue™ Safe Stain or proteins were transferred to
PVDF membranes for 60 min at 30 V using a XCell II
Table 1 Data from Hazelnut allergic patients
Source Reference Age Gender Hazelnut allergy Other food allergies Other allergies
symptoms SPT CAP specific
IgE (kU/L)
Strasbourg,
France
1 49 f Rhinitis, Conjunctivitis,
Asthma
++ 9.7 kiwi, ananas no
2 17 m Rhinitis, Conjunctivitis ++ >100.0 peanut, apple, celery, soya,
walnut, sesame, kiwi, carrot,
tomato, cherry, fig
cat
3 25 f Rhinitis, Conjunctivitis ++ 31.2 no
4 30 m Rhinitis, Conjunctivitis,
Asthma
+ 1 house dust mite
5 33 f Rhinitis, Conjunctivitis,
Asthma
++ >100.0 cat
Athens,
Greece
6 42 f + 1.7 peanut, cabbage, pepper,
honey
Resp Allergy Rhinitis
7 24 f − 2.6 almond Resp Allergy Rhinitis, Asthma
8 21 m OAS + 1.0 eggplant no
9 36 m Asymptomatic
sensitization
− 3.0 walnut Resp Allergy Rhinitis
10 27 m OAS ++ 5.1 peanut, walnut, almond,
cashew, pistachio, peach,
apple, appricot, mustard, corn
Resp Allergy Rhinitis, Asthma
11 21 f OAS + 0.5 peach, walnut Resp Allergy Rhinitis
12 18 f Asymptomatic
sensitization
− 28.5 cabbage, wheat no
13 Hazelnut allergy
history
14 8 m OAS ++ n/a egg no
15
16 hazelnut allergy
history
Madrid,
Spain
17 34 f urticaria + contact
urticaria
++ 5.1 lentil, chickpea, bean, pea,
soybean, sunflower seed,
pine nut
grass and olive pollen allergies -
rhinoconjunctivitis and asthma
18 4 m OAS ++ 2.3 walnut NO
19 16 f tongue angioedema ++ 7.3 walnut, vetchling pollen allergy - rhinoconjunctivitis
and asthma - due to grass, cypress
and plane tree pollens
Zurich,
Switzerland
20
21
Asymptomatic sensitization: SPT results (−,+ or ++ according to the SPT/histamine wheal size ratio) or/and specific IgE (CAP) to hazelnut in the absence of
clinical symptoms
No information was available for Zurich patients
OAS Oral Allergy Syndrom
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blot module. The membranes were saturated with TBST
(20 mM Tris, pH 8.0, 0.25 M NaCl, 0.5 % Tween) sup-
plemented with 5 % milk powder. Immunoblots were
performed with a pool of sera specific for Cor a 1.04
from birch-endemic region, or a pool of sera from
Athens specific for Cor a 8, Cor a 9 and Cor a 11. Sera
diluted 1/40 in TBST supplemented with 5 % milk pow-
der were incubated overnight at 4 °C. Membranes were
then washed using TBST, and a human anti-IgE monoclo-
nal Antibody (Star 96P, Serotec) labelled with peroxidase
was incubated for 2 h at room temperature. After several
washings using TBS (20 mM Tris, pH 8.0, 0.25 M NaCl),
the membrane was incubated with the ECL plus Western
blotting detection reagent (Amersham GE Healthcare,
Buckinghamshire, UK) for 5 min and images then ac-
quired using VersaDoc Imaging System (BioRad, Hercules,
CA).
Basophil histamine release assay
PBMCs were isolated from 20 mL of fresh buffy coats
(Blood Bank, National University Hospital of Copenhagen,
Denmark) using the lymphoprep isolation method. After
isolation PBMCs were washed twice in physiologic saline
and IgE were removed by exposing the cell pellet to strip-
ping buffer (RefLab, Copenhagen, Denmark; 4 °C for
5 min). After centrifugation, cells were washed twice with
Pipes buffer (RefLab) and finally resuspended to a final
volume of 2 mL. Aliquots of 100 μl stripped cells were in-
cubated with 100 μl undiluted patient serum or one sera
from non allergic patient as a control for 1 h at 37 °C and
then resuspended in 3 mL of a washed erythrocyte ob-
tained from the lymphoprep separation suspension con-
taining IL-3 (2 ng/mL). Twenty-five microliters of the
passively sensitized cell suspension was incubated with
25 μl of different concentrations of hazelnut extract or
purified hazelnut allergens (Cor a 9, Cor a 11, rCor a 1.04
and rCor a 8) for 1 h at 37 °C on HR-Test Plate (RefLab,
Copenhagen, Denmark). Anti-IgE or buffer was used as
positive (reference) and negative control, respectively.
After washing, released histamine was detected fluoromet-
rically according to the method described by Stahl et al.
[19]. A net histamine release > 10 ng/mL was considered
as a positive response and histamine release was expressed
as percentage of reference release. Results were also given
in classes 0–6, taking into account the range of allergen
concentration inducing a significant histamine release (the
lower this concentration is, the higher the class is).
Results
Sensitization pattern
Total and specific IgE
Whatever the regional origin of the patient, total IgE
showed a great variability ranging from less than 15 to
4500 IU/mL (Table 2). Patients’ sera were considered
positive when specific IgE were detected against at least
one of the four allergens, i.e., rCor a 1, rCor a 8, Cor a 9
and Cor a 11. All patient sera from Spain, 9 out of the
11 patient sera from Greece, and 6 out of the 7 patient
sera from Switzerland and East of France were positive
(Table 2; sensitization pattern depending on geograph-
ical area is depicted Fig. 1). Within positive sera, those
coming from patients from France and Switzerland dem-
onstrated IgE exclusively directed against rCor a 1.04
whereas none of the positive patient’s sera from Greece
demonstrated IgE specific to this allergen. Conversely,
most of the positive Greek sera (8 out of 9) had specific
IgE directed against rCor a 8. Sera from 2 out of the 3
patients recruited in Spain showed intermediate pat-
terns, with both specific IgE to rCor a 8 and rCor a 1.04.
The third one demonstrated only Cor a 9-specific IgE
(Patient #18).
Only few sera had specific IgE directed against either
Cor a 11 or Cor a 9. They all came from patients re-
cruited in Greece (5/11 and 3/11 respectively) and Spain
(1/3 in each case). The higher levels of specific IgE
against these two allergens were demonstrated in a pa-
tient from Greece that demonstrated low levels of anti-
rCor a 8 IgE (Patient #14).
IgE immunoblot
Pools of sera from patients sensitized exclusively to Cor
a 1.04 (birch-endemic region pool) or from patients sen-
sitized to Cor a 8, Cor a 9 and Cor a 11 (Greek pool)
were constituted to further analyse their sensitization
pattern by IgE-immunoblot. Far more bands were re-
vealed using sera from Greece when compared to birch-
endemic region pool that demonstrated very restricted
recognition pattern. As evidenced using sera from the
birch endemic region, Cor a 1 was intensively recognized
when analysing purified recombinant allergen (Fig. 2b,
lane 5). However, Cor a 1 recognition was far less in-
tense within the complex hazelnut extract (Fig. 2b, lane
2). Conversely, another band, at MW below that of Cor
a 1, was more intensively revealed by IgE-immunoblot.
Electrophoresis pattern of purified Cor a 11 and Cor a
9 evidenced several bands (Fig. 2a), as previously de-
scribed [14]. Cor a 11 polypeptides with apparent MW
of 47 KDa were evidenced whereas the 31–35 KDa
bands were hardly visible, suggesting degradation of the
corresponding entities–certainly as several intense bands
between 20 and 30 KDa (Fig. 2a, lane 2). All those Cor a
11-related bands were slightly recognized by IgE from
Greek pool sera (Fig. 2c, lane 3), and not recognized at
all by IgE from birch-endemic region pool (Fig. 2b, lane
3). Basic (21–25 KDa) and acidic chains (31–35 KDa) of
11S globulin Cor a 9 were also clearly evidenced by elec-
trophoresis (Fig. 2a, lane 3), as the same as lower MW
polypeptides between 9 and 12 KDa. Basic and acidic
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bands were recognised by IgE from the Greek pool, as
evidenced both using the purified allergen (Fig. 2c, lane
4) and the hazelnut extract (Fig. 2c, lane 2). IgE immu-
noblot also demonstrated the intense recognition of
rCor a 8 only by the Greek pool sera (lane 6: rCor a 8
and lane 2: hazelnut extract). Another band, at MW below
that of Cor a 8, was also revealed by IgE-immunoblot with
Greek pool.
Histamine release
HR tests were performed for all the sera collected in France/
Switzerland (n = 7), Spain (n = 3) and Greece (n= 11). All
sera from allergic patients tested induced histamine release
after challenge with the hazelnut extract, whereas serum
from non allergic patient did not (data not shown). Typical
results obtained with 4 sera are shown Fig. 3 and Baso-
phil histamine release classes obtained from all the sera
Fig. 1 Sensitization pattern depending on the geographical origin of the patient. Specific IgE against Cor a 11, Cor a 9, rCor a 1.04 and rCor a 8
were assayed by EAST
Table 2 Total IgE and Cor a 11-, Cor a 9-, rCor a 1.04- and rCor a 8-specific IgE in sera, depending on the regional origin of the patients
Origin Reference Total IgE
(IU/mL)
Specific IgE (IU/mL)
Cor a 11 (7S globulin) Cor a 9 (11S globulin) rCor a 1.04 (Bet v 1 like) rCor a 8 (nsLTP)
Strasbourg, France 1 19 – – 2.5 –
2 183 – – 84.7 –
3 52 – – 10.8 –
4 <15 – – – –
5 757 – – 134.5 –
Athens, Greece 6 176 – – – 10.0
7 891 1.5 – – 9.3
8 <15 – – – 2.4
9 189 1.9 – – –
10 898 – – – 8.2
11 118 – – – –
12 861 0.9 – – 137.0
13 500 3.2 4.7 – 9.5
14 1027 85.4 72.3 – 2.2
15 1591 – 4.8 – 67.2
16 29 – – – –
Madrid, Spain 17 779 – – 2.1 14.0
18 72 – 0.8 – –
19 4537 4.6 – 4.5 10.9
Zurich, Switzerland 20 275 – – 31.3 –
21 4350 – – 109.2 –
(− = < limit of detection (0.1 IU/mL))
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depending of their geographical origin are gathered
Fig. 4. Globally, good correlation was observed between
IgE titers (Fig. 1) and HR assay. The 2 sera from Greece
(#11 and #16) and sera from Strasbourg (#4) negative
for specific IgE demonstrated low HR using the hazel-
nut extract (BHR class 1), whereas no allergen-specific
HR was detected for these sera.
Figure 3a and b shows typical results obtained with 1
serum from Switzerland and France, respectively. Among
all sera from patients coming from France and Switzerland,
6 out of 7 demonstrated rCor a 1-specific HR, whereas
none of them demonstrated rCor a 8, Cor a 9 nor Cor a
11-specific HR, correlating with specific IgE. Sera in Fig. 3
demonstrated high (patient #21, Fig. 3a) or low (patient #1,
Fig. 2 IgE immunoblot using pooled sera from birch endemic region or from Greece. (a) Electrophoresis profile of purified Cor a 11 (lane 2), purified
Cor a 9 (lane 3) and hazelnut extract (lane 4). IgE immunoblot using pool of sera from birch-endemic region (b) or from Greece (c) using hazelnut
extract (lane 2), purified Cor a 11 (lane 3), purified Cor a 9 (lane 4), rCor a 1.04 (lane 5) or rCor a 8 (lane 6). Molecular weights (lane 1) are indicated
Fig. 3 Basophil histamine release induced by hazelnut allergens depending on the geographical origin of the sensitizing sera. Stripped human
basophils were passively sensitized with serum #21 (Zurich–a), #1 (Strasbourg–b), #8 or #12 (Athens, c and d respectively) and then incubated
with increasing concentration of hazelnut allergens, i.e., hazelnut extract (black), rCor a 1 (red), rCor a 8 (blue), Cor a 9 (purple) or Cor a 11 (green).
Released histamine is represented as percentage of reference release, i.e., induced by anti-IgE
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Fig. 3b) rCor a 1-specific IgE concentrations (Table 2).
Additional results using 3 other sera from France with vari-
ous specific IgE titers are shown in Additional file 1: Figure
S1. No clear correlation between rCor a 1-specific IgE con-
centrations and HR intensity could be evidenced.
On the opposite, sera from Greek patients induced
mainly Cor a 8-specific HR, at very low doses of allergen
(Fig. 3c and d showing two sera from Greece), suggest-
ing a high elicitation potency of this allergen. All the
sera of patients from Spain induced HR after rCor a 8
challenge (even patient #18 who did not demonstrated
specific IgE), but not after rCor a 1 challenge, although
rCor a 1 specific IgE were detected in 2 of these 3 sera.
One of them demonstrated HR after Cor a 9 and Cor a
11 challenge, but at the highest tested doses. Globally,
Cor a 9 and Cor a 11-specific HR were less frequent
(Cor a 9: 3 sera from Greek patients, 1 serum from
Spain; Cor a 11: 4 sera from Greece, 1 serum from
Spain, 2 sera from France; Fig. 4). Considering those al-
lergens, HR occurred at higher doses than those ob-
served for rCor a 8 (Fig. 3d).
Discussion
The results obtained in our adult population confirm
that hazelnut allergic patients from Mediterranean coun-
tries are mainly sensitized to Cor a 8 whereas patients
from Northern Europe are sensitized to pollen-related
allergens such as Cor a 1.04 [2, 4, 5, 8]. In fact, in our
population, Cor a 1.04 sensitization was clearly evi-
denced in French and Swiss patients when using EAST
or IgE immunoblot with purified recombinant allergen,
correlating with the very high frequency of recognition
(>80 %) of this allergen within Strasbourg and Zurich co-
horts of Europrevall [2]. It is to note however that another
IgE-reactive protein is evidenced by IgE immunoblot using
Birch-endemic pool, leading to an even more intense sig-
nal than Cor a 1 within the hazelnut extract (Fig. 2b). This
protein could correspond to another pollen-related aller-
gen such as Cor a 2 (MW 14 KDa vs Cor a 1 MW 17–
18 KDa, [4, 20]). In fact, Cor a 2 was also recognized by
about 19 % of Zurich and Strasbourg patients within Euro-
prevall cohorts [2], by 26 % of patients form Zurich and
Copenhagen [4] and up to 42 % in hazelnut allergic pa-
tients from Switzerland or Denmark [8]. Using purified al-
lergens and ImmunoCAP, the IgE concentrations against
rCor a 1 were demonstrated to be far higher than that
against rCor a 2 [2, 8], but our study suggests that the
contents and/or the allergenic activity [21] of the relative
allergens within the hazelnut extract have also to be taken
into consideration to further assess their relative contribu-
tion in hazelnut allergy. This is further confirmed when
comparing elicitation potency of rCor a 1.04 vs hazelnut
extract (see below).
Conversely, no Cor a 1.04 sensitization was evidenced
in the Greek patients whereas Cor a 8 sensitization was
observed in 8 out 9 of the sensitized patients from
Athens, comforting recent data [2]. Within these 8 pa-
tients and considering the allergens we tested, 3 patients
were monosensitized to Cor a 8. In a study involving 26
hazelnut patients from Spain, in which 10 patients dem-
onstrated anaphylactic reaction, rCor a 8 was recognized
by 62 to 77 % of the patients, most of them being mono-
sensitized, whereas only 1 patient demonstrated IgE against
rCor a 1.04 and none against rCor a 2 [5]. Interestingly, the
3 Spanish patients in the present study demonstrated inter-
mediate sensitization profiles, 2 of them demonstrating
both rCor a 1.04 and rCor a 8 specific IgE.
We observed sensitization to seed storage proteins
Cor a 9 and Cor a 11 in 55 and 33 %, respectively, of the
sensitized patients from Athens (n = 9), and 1 out 3 pa-
tients from Madrid. None of the French nor Swiss pa-
tients tested (n = 7) demonstrated specific IgE against
these proteins. The IgE-immunoblot using the Greek
pool confirmed sensitization to Cor a 8, Cor a 9 and Cor
a 11. It is to note that purified Cor a 9 used in the
present study may also contain isoallergen of Cor a 9,
notably its 20.7 KDa IgE reactive subunit recently de-
scribed in Italian paediatric patients ([13], Fig. 2c).
Fig. 4 BHR classes depending on the geographical origin of the sensitizing sera and of the purified allergens. BHR class represent the range of
allergen concentration inducing a significant histamine release
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Others bands suggest also sensitization to the 2S albu-
min Cor a 14 (MW around 9 KDa, Fig. 2c) in the Greek
population, an allergen that allowed identifying almost
90 % of children with generalized reactions to hazelnut
[12]. This is in accordance with the fact that all patients
sensitized to Cor a 14 were also sensitized to Cor a 9
[2]. Unfortunately, we didn’t assay corresponding IgE in
individual sera.
Interestingly, the higher sensitization to Cor a 9 and
Cor a 11 was observed in one of the 2 children of our
population, i.e., patient #14, a 8-year old child from
Athens. The other child, a 4-year-old from Madrid was
monosensitized to Cor a 9 (patient #18). In our re-
stricted population, none of the adults from the 2 birch-
endemic regions were sensitized to these allergens. This
is in accordance with the observation that sensitization to
Cor a 11 was not or rarely found in hazelnut-allergic
adults from birch-endemic region such as the Netherlands
and Belgium [7, 22], whereas sensitization to Cor a 11 was
evidenced in children of such area, mainly in infants dem-
onstrating severe reaction. In birch-endemic region, Cor a
9 (and Cor a 14) sensitization was evidenced as soon as
preschool age in infants with atopic dermatis, preceding
sensitization to Cor a 11, and in children demonstrating
severe symptoms [7, 11, 12].
The biologic activity of the 4 tested allergens was then
analysed by histamine release assay, further confirming
the sensitization patterns observed in EAST and IgE im-
munoblot, and the efficiency of the interaction between
these sera and the corresponding specific allergen. We
can observe that for some patients and allergens, the
presence of specific IgE is not confirmed by HR. For ex-
ample, rCor a 1.04 specific IgE were detected in 2 pa-
tients from Spain (patients #17 and #19), but were not
associated with basophil activation. This can reflected
IgE cross reactivity with others Bet v 1 pollen allergens,
as these two patients were allergic to grass and olive or
grass, cypress and plane tree pollens, but not clinical re-
activity. The biological activity of nCor a 11 [7] or nCor
a 9, rCor a 1 and rCor a 8 [6] was also studied using
Basophil activation test and selected sera from birch-
endemic region. In this study, the most active allergen,
i.e., the allergen activating basophils at the lower dose,
was Cor a 1. In the present study we demonstrated that
the activity of rCor a 8 is very high in the Athens pa-
tients, with elicitation potency and BHR classes higher
than that observed for the reference hazelnut extract. In
contrast, HR release induced by rCor a 1.04 was far less
efficient in patients from France and Switzerland. In
these patients, the most efficient release was induced by
the hazelnut extract, thus confirming the presence of
other IgE reactive protein(s) for these patients in the
extract. BHR classes for Cor a 9 and Cor a 11 in
respective-sensitized patients were lower. Altogether,
this thus suggests that rCor a 8 is a more potent elicitor
than the other tested allergens, which can also partially
explain the more severe symptoms in the patients sen-
sitized to this allergen [4, 5].
Conclusions
Although based on a limited number of patients, this
work extends previously published researches on the
sensitizing profiles of hazelnut allergic patients in birch-
endemic versus Mediteranean regions and provides new
data on the biological activity of hazelnut allergens and
extracts. Notably, the present study demonstrates the
high biological activity of Cor a 8 and the IgE reactivity
and functionality of other pollen-related proteins in
hazelnut extract.
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Additional file 1: Figure S1. Basophil histamine release induced by
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(black), rCor a 1 (red), rCor a 8 (blue), Cor a 9 (purple) or Cor a 11 (green).
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